| Financial Year |
March 31 2023 |
| Monetary Funds |
104,253,404.21 |
| Held-for-trading Financial Assets |
126,889,429.56 |
| Notes Receivable |
1,995,578.50 |
| Accounts Receivable |
303,497,883.67 |
| Advances to Suppliers |
7,804,903.75 |
| Other Receivables |
11,718,840.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
200,163,774.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,751,620.07 |
| Total Current Assets |
801,569,348.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
27,559,576.11 |
| Investment Properties |
105,175,408.50 |
| Fixed Assetes |
80,577,898.59 |
| Under-construction Projects |
119,789,817.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,098,825.26 |
| R&D expenses |
-- |
| Goodwill |
16,808.14 |
| Long-Term Deferred and Prepaid Expenses |
14,115,630.69 |
| Deferred Income Tax Assets |
10,557,829.02 |
| Other Non-Current Assets |
1,972,707.63 |
| Sub-Total of Non-Current Assets |
389,305,413.19 |
| Total Assets |
1,190,874,761.44 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
58,758,501.71 |
| Accounts Payable |
108,107,438.63 |
| Accounts Received In Advance |
780,554.60 |
| Employee Compensation Payable |
10,457,357.63 |
| Taxes Payable |
8,246,832.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,297,762.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
4,337,487.14 |
| Sub-Total of Current Liabilities |
245,351,219.72 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
-- |
| Total Liabilities |
245,351,219.72 |
| Paid-In Capital(Or Share Stock) |
68,000,000.00 |
| Capital Surplus |
540,679,718.60 |
| Surplus Reserve |
34,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
302,843,823.12 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
945,523,541.72 |
| Owner's Equity（Stockholder's Equity） |
945,523,541.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,190,874,761.44 |
